Call Number (LC) | Title | Results |
---|---|---|
HD9666.4 .I77 | Issues in pharmaceutical economics / | 1 |
HD9666.4 .L55 |
Lilly digest. Lilly digest of the ... statements of ... retail drug stores. |
2 |
HD9666.4 L55 |
NARD-Lilly digest. Lilly digest of the ... statements of ... retail drug stores. |
2 |
HD9666.4 .L73 | NARD-Lilly digest. | 1 |
HD9666.4 .M38 | Marketing guide. | 1 |
HD9666.4 .M66 2019 | Medicine price surveys, analyses and comparisons : evidence, methodology and guidance / | 1 |
HD9666.4 .N29a |
NACDS : [Lilly statistical digest] NACDS-Lilly digest. |
2 |
HD9666.4 .N3 | Distribution through drug channels in the 84 wholesale trading areas. : Facts important to the manufacturer on the coverage of independent drug stores / | 1 |
HD9666.4 .N67 | Prescription drug pricing in independent and chain drugstores : an examination of the data / | 1 |
HD9666.4 .O75 | Fair trade and the retail drug store : a price study of leading drug store proprietary items under minimum price contracts permitted by fair trade laws / | 1 |
HD9666.4 .Q54 2017 | Prescription for the People An Activistâ#x80;#x99;s Guide to Making Medicine Affordable for All / | 1 |
HD9666.4 .Q54 2018 | Prescription for the people : an activist's guide to making medicine affordable for all / | 1 |
HD9666.4 .R47 | Report to the President prescription drug coverage, spending, utilization, and prices / | 2 |
HD9666.4 .S38 | Innovation in the pharmaceutical industry / | 1 |
HD9666.4 .S578 1997 | Should pharmaceutical prices be regulated : the strengths and weaknesses of the British Pharmaceutical Price Regulation Scheme / | 1 |
HD9666.4 .U55 1992a | Prescription drugs : companies typically charge more in the United States than in Canada : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives / | 1 |
HD9666.4 .W35 1971 | Market power and price levels in the ethical drug industry / | 1 |
HD9666.5 |
Supply chain management in pharmaceutical industry / Pharmaceutical economics and policy : perspectives, promises, and problems / NEW DRUGS, FAIR PRICES managing the pharmaceutical innovation ecosystem for... sustainable and affordable new medicines. Industrial hygiene in the pharmaceutical and consumer healthcare industries / |
4 |
HD9666.5 .A56 | The drug makers and the drug distributors. | 1 |
HD9666.5 .A74 2004 | The truth about the drug companies : how they deceive us and what to do about it / | 1 |